Willow Street Advisors’s GSK GSK Stock Holding History

Willow Street Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$307K	Hold	4,600	–	–	0.17%	121
2013 Q3	$289K	Hold	4,600	–	–	0.18%	120
2013 Q2	$287K	Buy	+4,600	New	+$292K	0.18%	118

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Willow Street Advisors's GSK Position: Q4 2013 in Review

Willow Street Advisors held its GSK (GSK) position steady in Q4 2013 at 4,600 shares worth $307K. The position accounts for 0.17% of the portfolio, ranked #121.

Willow Street Advisors first reported a position in GSK in Q2 2013 and has held it in 3 quarters since. 681 funds tracked by Wall St. Rank hold GSK as of Q4 2013.

Willow Street Advisors held 4,600 shares of GSK worth $307K as of Q4 2013.
Willow Street Advisors left its GSK share count unchanged in Q4 2013.
GSK made up 0.17% of Willow Street Advisors's portfolio in Q4 2013, its #121 holding.
Willow Street Advisors first reported a position in GSK in Q2 2013 and has held it in 3 quarters since.
681 funds tracked by Wall St. Rank held GSK as of Q4 2013.

Based on Willow Street Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.